FTC, Surescripts Debate Liu's Impact On Monopolization Case
Law360 (July 14, 2020, 9:35 PM EDT) -- The Federal Trade Commission and Surescripts offered dueling interpretations of how the antitrust watchdog's monopolization case against the e-prescription service is potentially impacted by the U.S. Supreme Court's recent holding that the U.S. Securities and Exchange Commission has the ability to collect disgorgement — with some new parameters.
The debate unfolded in separate briefs Monday in response to a June order U.S. District Judge John D. Bates issued instructing the parties to explain what bearing, if any, the justices' 8-1 decision in Liu v. SEC has on the case.
The high court ruled last month that the top securities regulator can obtain...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!